Drug Interactions between Opioids and Antiretroviral Medications: Interaction between Methadone, LAAM, and Nelfinavir
- 4 March 2004
- journal article
- Published by Wiley in The American Journal on Addictions
- Vol. 13 (2) , 163-180
- https://doi.org/10.1080/10550490490436037
Abstract
Understanding drug interactions between antiretrovirals and opiate therapies may decrease toxicities and enhance adherence, with improved HIV outcomes in injection drug users. We report results of a clinical pharmacology study designed to examine the interaction of the protease inhibitor, nelfinavir, with methadone and LAAM (N = 48). Nelfinavir decreased methadone exposure, but no withdrawal was observed over the five day study period. LAAM and dinor LAAM concentrations were decreased, while nor LAAM concentrations were increased, with minimal overall change in LAAM / metabolite exposure. Methadone and LAAM did not affect nelfinavir concentrations, but methadone decreased M8 metabolite exposure. While no toxicities were observed, clinicians should be aware of the potential for drug interactions when patients require treatment with nelfinavir and these opiate medicatioons. (Am J Addict 2004;13:163–180)Keywords
This publication has 27 references indexed in Scilit:
- The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus–Infected Persons in Clinical TrialsClinical Infectious Diseases, 2002
- Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patientsAIDS, 2001
- NelfinavirDrugs, 2000
- The Effect of Increasing α1‐Acid Glycoprotein Concentration on the Antiviral Efficacy of Human Immunodeficiency Virus Protease InhibitorsThe Journal of Infectious Diseases, 1999
- The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic responseAIDS, 1999
- The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors.Journal of Clinical Investigation, 1998
- Involvement of Cytochrome P450 3A4 Enzyme in the N-Demethylation of Methadone in Human Liver MicrosomesChemical Research in Toxicology, 1996
- Inhibition of human cytochrome P450 2D6 (CYP2D6) by methadone.British Journal of Clinical Pharmacology, 1993
- Two New Rating Scales for Opiate WithdrawalThe American Journal of Drug and Alcohol Abuse, 1987
- Cardiac effects of 1-α-acetylmethadol (LAAM) in different speciesGeneral Pharmacology: The Vascular System, 1979